FDA Yanks Rule Shielding Docs In Misconduct Inquiries
The agency said it received “significant adverse comment” in response to the proposal, which would create exemptions from Privacy Act disclosure requirements, but declined a request to elaborate. The Federal Register shows that four comments were submitted on the plan, but the comments weren’t immediately available.
When the plan was unveiled in August,...
To view the full article, register now.